Late SV40 factor:A key mediator of Notch signaling in human hepatocarcinogenesis  

作　　者：Ren-Hua Fan Jing Li Nan Wu Ping-Sheng Chen 

机构地区：[1]Department of Pathology,School of Medicine,Southeast University,Nanjing 210009,Jiangsu Province,China

出　　处：《World Journal of Gastroenterology》2011年第29期3420-3430,共11页世界胃肠病学杂志（英文版）

基　　金：Supported by The National Natural Science Foundation of China,No.30470780

摘　　要：AIM:To investigate the relationship between late SV40 factor(LSF)and Notch signaling in the development and progress of hepatocellular carcinoma(HCC).METHODS:Liver cancer tissue specimens from 25 patients were analyzed for Notch-1 and LSF expression by immunohistochemistry.The correlation between expression and the biological effects of Notch-1 and LSF were analyzed using genetic and pharmacological strategies in HCC cell lines and human normal cell lines,including hepatic stellate cells(HSC)and human embryonic kidney epithelial cells(HEK).RESULTS:Immunohistochemistry showed that both Notch-1 and LSF were significantly upregulated in HCC samples(76%,19/25,P<0.0001 and 84%,21/25,P<0.0001,respectively)compared with non-cancer samples.Activation of Notch-1 by exogenous transfection of Notch1 intracellular domain increased LSF expression in HSC and HEK cells to levels similar to those seen in HepG2 cells.Furthermore,blocking Notch-1 activation with aγ-secretase inhibitor,DAPT,downregulated LSF expression in HepG2 cells.Additionally,a biological behavior assay showed that forced overexpression of LSF promoted HepG2 cell proliferation and invasion.CONCLUSION:LSF is a key mediator of the Notch signaling pathway,suggesting that it might be a novel therapeutic target for the treatment of HCC.AIM：To investigate the relationship between late SV40 factor（LSF）and Notch signaling in the development and progress of hepatocellular carcinoma（HCC）.METHODS：Liver cancer tissue specimens from 25 patients were analyzed for Notch-1 and LSF expression by immunohistochemistry.The correlation between expression and the biological effects of Notch-1 and LSF were analyzed using genetic and pharmacological strategies in HCC cell lines and human normal cell lines,including hepatic stellate cells（HSC）and human embryonic kidney epithelial cells（HEK）.RESULTS：Immunohistochemistry showed that both Notch-1 and LSF were significantly upregulated in HCC samples（76%,19/25,P0.0001 and 84%,21/25,P0.0001,respectively）compared with non-cancer samples.Activation of Notch-1 by exogenous transfection of Notch1 intracellular domain increased LSF expression in HSC and HEK cells to levels similar to those seen in HepG2 cells.Furthermore,blocking Notch-1 activation with aγ-secretase inhibitor,DAPT,downregulated LSF expression in HepG2 cells.Additionally,a biological behavior assay showed that forced overexpression of LSF promoted HepG2 cell proliferation and invasion.CONCLUSION：LSF is a key mediator of the Notch signaling pathway,suggesting that it might be a novel therapeutic target for the treatment of HCC.

关 键 词：Notch receptor Late SV40 factor Signal transduction Hepatocellular carcinoma 

分 类 号：Q421[生物学—神经生物学] Q257[生物学—生理学]